Bod links with Uni of Syd­ney’s Lam­bert

Pharmacy Daily - - Front Page -

MEDIC­I­NAL cannabis and health prod­ucts com­pany Bod has an­nounced it has en­tered a re­search col­lab­o­ra­tion with the Univer­sity of Syd­ney Lam­bert Ini­tia­tive for the de­vel­op­ment of a com­pound marker re­quired in the Phase I clin­i­cal trial of Bod’s sub­lin­gual cannabis wafer.

The Lam­bert Ini­tia­tive was formed in 2015 fol­low­ing a $33.7m dona­tion from the Lam­bert fam­ily to the univer­sity for re­search into ther­a­peu­tic uses of medic­i­nal cannabis.

The grant will cover around 50% of the to­tal project costs.

Bod says the Phase I Clin­i­cal trial con­tin­ues with ini­tial re­sults ex­pected in Nov 2018.

Newspapers in English

Newspapers from Australia

© PressReader. All rights reserved.